Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis-Type Psoriasis”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01582932
What this trial is testing

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 36
Testing effectiveness (Phase 2)Looking for participantsNCT07410793
What this trial is testing

Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.

Who this might be right for
Plaque Type Psorisis
Mae Fah Luang University 28
Testing effectiveness (Phase 2)Study completedNCT00885196
What this trial is testing

A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

Who this might be right for
Moderate and Severe Plaque Psoriasis
Novartis Pharmaceuticals 336
Large-scale testing (Phase 3)Study completedNCT01636687
What this trial is testing

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 182
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Early research (Phase 1)Study completedNCT03337022
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
Celgene 34
Testing effectiveness (Phase 2)Study completedNCT00521339
What this trial is testing

Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis

Who this might be right for
Psoriasis-Type PsoriasisPlaque-Type Psoriasis
Amgen 31
Testing effectiveness (Phase 2)Study completedNCT01154101
What this trial is testing

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Sirtris, a GSK Company 40
Early research (Phase 1)Ended earlyNCT02936492
What this trial is testing

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

Who this might be right for
Psoriasis
Bayer 32
Testing effectiveness (Phase 2)Study completedNCT00773734
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

Who this might be right for
PsoriasisPlaque-type Psoriasis
Amgen 352
Testing effectiveness (Phase 2)Study completedNCT01071252
What this trial is testing

A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 125
Large-scale testing (Phase 3)Study completedNCT02660580
What this trial is testing

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Type PsoriasisModerate to Severe Plaque Psoriasis
Fresenius Kabi SwissBioSim GmbH 443
Testing effectiveness (Phase 2)Study completedNCT01831466
What this trial is testing

Tofacitinib Ointment For Chronic Plaque Psoriasis

Who this might be right for
Psoriasis VulgarisPsoriasis
Pfizer 476
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Large-scale testing (Phase 3)Study completedNCT02394561
What this trial is testing

A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)

Who this might be right for
Plaque Type Psorisis
Novartis Pharmaceuticals 434
Large-scale testing (Phase 3)Not Yet RecruitingNCT07432854
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Dermavon Holdings Limited 540
Large-scale testing (Phase 3)Study completedNCT01358578
What this trial is testing

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 1,306
Not applicableStudy completedNCT02929745
What this trial is testing

Single Cell Genomics of Psoriatic Skin

Who this might be right for
Psoriasis
University of California, San Francisco 16
Large-scale testing (Phase 3)Study completedNCT03047395
What this trial is testing

Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

Who this might be right for
Psoriasis
AbbVie 2,170
Testing effectiveness (Phase 2)Study completedNCT04207801
What this trial is testing

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Aurigene Discovery Technologies Limited 90
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation